AZ3451 is primarily used in research and development within the field of oncology. It functions as a selective inhibitor targeting specific pathways involved in cancer cell proliferation. This compound is particularly valuable in preclinical studies to understand the mechanisms of tumor growth and to evaluate the efficacy of potential therapeutic strategies. Researchers utilize AZ3451 to investigate its impact on cellular signaling pathways, often focusing on its ability to induce apoptosis or inhibit angiogenesis in cancer models. Its application extends to the development of targeted therapies, where it serves as a lead compound for optimizing drug candidates with improved selectivity and reduced side effects. Additionally, AZ3451 is employed in high-throughput screening assays to identify synergistic drug combinations that enhance anticancer activity. Its role in advancing personalized medicine is significant, as it helps tailor treatments based on the molecular profile of individual tumors.